Zenas BioPharma

Zenas BioPharma

To transform the lives of patients living with autoimmune diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
CAD1.1—1.6b (Dealroom.co estimates May 2024.)
Waltham Massachusetts (HQ)
  • Edit

Recent News about Zenas BioPharma

Edit
More about Zenas BioPharmainfo icon
Edit

Zenas BioPharma is a global biopharmaceutical company focused on developing and commercializing immunology-based therapies for patients with autoimmune diseases. The company operates in the biopharmaceutical market, targeting patients in need of innovative treatments for autoimmune conditions. Zenas BioPharma's business model centers on advancing a deep pipeline of therapeutics through successful business development strategies and partnerships. The company generates revenue by developing and commercializing these therapies, aiming to bring transformative solutions to patients worldwide. Zenas BioPharma serves a diverse client base, including healthcare providers, patients, and research institutions, and leverages its experienced leadership team and network of business partners to drive operational excellence.

Keywords: autoimmune, therapeutics, biopharmaceutical, immunology, innovative, pipeline, commercialization, partnerships, leadership, global.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.